Weight loss companies forced to change tactics by Ozempic and Wegovy.

Weight-loss companies like WeightWatchers and Noom are shifting their business models to offer prescriptions for obesity drugs like Wegovy and Ozempic, recognizing obesity as a chronic disease. The companies' decisions to expand into prescription medications came in response to an evolving scientific understanding of obesity, as well as to requests from customers looking to incorporate medications into their weight-loss regimens. The rise of these popular drugs has compelled weight-loss companies to fundamentally shift their business models.